Form 4: Guided Therapeutics Director Imhoff Acquires Shares and Warrants in $150,000 Transaction

John E. Imhoff, a director and 10% owner of Guided Therapeutics, acquired 1,666,667 shares of common stock and warrants to purchase an additional 1,666,667 shares for $150,000.

Summary

• On September 23, 2024, John E. Imhoff, a director and 10% owner of Guided Therapeutics, acquired 1,666,667 shares of common stock.
• He also acquired warrants to purchase an additional 1,666,667 shares of common stock.
• The aggregate purchase price for the shares and warrants was $150,000.
• The warrants are immediately exercisable and expire four years from the issuance date.
• The exercise price of the warrants is $0.12 per share.
• Following the transaction, Mr. Imhoff beneficially owns 7,075,898 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a standard transaction by a company insider. The director's investment could be seen as a positive signal, but it's a relatively small amount.

Positives

• A director's investment in the company may signal confidence in its future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This allows investors to monitor the actions of those with privileged information.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Guided Therapeutics, Imhoff, shares, warrants, acquisition, director, GTHP, beneficial ownership, securities